where R1 and R2 are similar or different and mean C1-C3-alkyls, Na or K; R1 - means hydrogen or methyl; R2 - means hydrogen, C1-C3-alkyl, benzyl or thiomethyl, or R1 and R2 together form alkylene chain. Compounds showed as excellent inhibitors of proline- and lysine hydroxylase, fibro- or immune depressants, curative agents at collagen and collagen-like substances metabolism disorder. EFFECT: enhanced effectiveness of inhibitors indicated above. 1 tbl"/>
INHIBITORS OF PROLINE- OR LYSINE HYDROXYLASE, FIBRO- OR IMMUNE DEPRESSANTS, CURATIVE AGENT USED AT DISORDERS OF COLLAGEN OR COLLAGEN-LIKE SUBSTANCES METABOLISM
首页>
外国专利>
INHIBITORS OF PROLINE- OR LYSINE HYDROXYLASE, FIBRO- OR IMMUNE DEPRESSANTS, CURATIVE AGENT USED AT DISORDERS OF COLLAGEN OR COLLAGEN-LIKE SUBSTANCES METABOLISM
INHIBITORS OF PROLINE- OR LYSINE HYDROXYLASE, FIBRO- OR IMMUNE DEPRESSANTS, CURATIVE AGENT USED AT DISORDERS OF COLLAGEN OR COLLAGEN-LIKE SUBSTANCES METABOLISM
展开▼
机译：脯氨酸或赖氨酸羟化酶抑制剂，纤维或免疫抑制剂，胶原蛋白或类似胶原蛋白物质代谢紊乱的治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: organic chemistry. SUBSTANCE: method involves the use of derivatives of oxalylamino acids of the formula (I) where R1 and R2 are similar or different and mean C1-C3-alkyls, Na or K; R1 - means hydrogen or methyl; R2 - means hydrogen, C1-C3-alkyl, benzyl or thiomethyl, or R1 and R2 together form alkylene chain. Compounds showed as excellent inhibitors of proline- and lysine hydroxylase, fibro- or immune depressants, curative agents at collagen and collagen-like substances metabolism disorder. EFFECT: enhanced effectiveness of inhibitors indicated above. 1 tbl
展开▼
